Vaccines · 2021 · 20 citations · 13 references
Kounis SyndromeHypertensionVascular DiseaseAllergy MedicineClinical PresentationAllergenType IiCoronary Artery DiseaseAcute Myocardial InfarctionClinical EpidemiologyPublic HealthCardiovascular Disease PathogenesisAtherosclerosisCardiologyCardiovascular ImagingMyocardial InfarctionPercutaneous Coronary InterventionAllergyCardiorenal SyndromesCardiovascular EpidemiologyAllergic ReactionsEpidemiologyCoronary Heart DiseaseCardiovascular DiseaseCoronary UnitComprehensive ReportFood AllergiesMedicineClinical AllergyCardiovascular GeneticsEmergency Medicine
Kounis syndrome (KS) has been defined as acute coronary syndrome (ACS) in the context of a hypersensitivity reaction. Patients may present with normal coronary arteries (Type I), established coronary artery disease (Type II) or in-stent thrombosis and restenosis (Type III). We searched PubMed until 1 January 2020 for KS case reports. Patients with age <18 years, non-coronary vascular manifestations or without an established diagnosis were excluded. Information regarding patient demographics, medical history, presentation, allergic reaction trigger, angiography, laboratory values and management were extracted from every report. The data were pulled in a combined dataset. From 288 patients with KS, 57.6% had Type I, 24.7% Type II and 6.6% Type III, while 11.1% could not be classified. The mean age was 54.1 years and 70.6% were male. Most presented with a combination of cardiac and allergic symptoms, with medication being the most common trigger. Electrocardiographically, 75.1% had ST segment elevation with only 3.3% demonstrating no abnormalities. Coronary imaging was available in 84.8% of the patients, showing occlusive lesions (32.5%), vascular spasm (16.2%) or normal coronary arteries (51.3%). Revascularization was pursued in 29.4% of the cases. In conclusion, allergic reactions may be complicated by ACS. KS should be considered in the differential diagnosis of myocardial infarction with non-obstructive coronary arteries.
13
Borja Ibáñez, Stefan James, Stefan Agewall et al. · European Heart Journal · 2017 · 9.5K citations · Full text
Evidence-based Medicine, Clinical Guidelines, Coronary Artery Disease +19
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Tom Thurén, Jean MacFadyen et al. · New England Journal of Medicine · 2017 · 8.7K citations · Full text
Jean‐Philippe Collet, Hölger Thiele, Emanuele Barbato et al. · European Heart Journal · 2020 · 4.9K citations · Full text
Heart Failure, Coronary Artery Disease, Acute Myocardial Infarction +19